Drug Information Whitepapers
Elsevier was built on the belief that there is nothing more important than having the right information so you can make the best decisions. It drives our product development – but is also reflected in our dedication to sharing our expertise and experience with the industry.
Achieving MAC Optimization with PAC: A PBM Best Practice
Achieving MAC Transparency and Optimization comes with analyzing pricing data on a regular basis and utilizing information from all pricing resources.
Chronic Disease Management
This white paper examines how health care payers are expanding and improving their well-established disease management programs
Controlling Prescription Drug Abuse
Controlling Prescription Drug Abuse examines what pharmacies need to know about controlled substance abuse.
Medicine Adherence and Star Ratings
White paper on STAR ratings and understand how payers and pharmacists are developing strategies to improve medication adherence.
Pharmacies on the Front Line
This epidemic of legal, controlled substance abuse creates challenges for pharmacists whom are the final checkpoint before dispensing prescriptions.
Predictive Acquisition Cost - Drug Pricing Made Transparent
CMS requires all Medicare Part D plans and their pharmacy benefit managers to make their MAC pricing standards.
Rising Generic Drug Prices
The reasons behind rising generic drug costs are multiple and complex. Understand the factors driving price increases.
Rising Generic Drug Prices: Impact of Biosimilars
Whitepaper discusses policy issues, success factors and the potential impact of biosimilars on drug prices and healthcare.
Spanish is Not Enough: The Multilingual Advantage for Pharmacies
Understand the competitive advantages pharmacies gain by offering info in multiple languages.
The Expanding Role of Pharmacy to Cut Readmissions
A team-based approach to managing patients with chronic conditions, and using data analytics to identify patients at risk.
The Significance of TRUE Daily Updates
Health care professionals depend on timely and accurate drug information to make evidence-based decisions.